checkAd
    Startseite > Aktien > Satellos Bioscience > Nachrichten
    Satellos Bioscience Aktie
    0,3560
     
    EUR
    +3,49 %
    +0,0120 EUR
    Letzter Kurs 31.05.24 Tradegate
    0,3420
     
    EUR
    4.398 STK
    Geldkurs 31.05.24
    0,3680
     
    EUR
    4.062 STK
    Briefkurs 31.05.24
    ISIN: CA80401L3083 · WKN: A3CSSM · SYM: 0ITA · Kanada

    Neueste Nachrichten

    Satellos Announces Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy
    28.05.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders
    14.05.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos Bioscience Announces Q1 2024 Financial Results and Operational Highlights
    14.05.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
    08.04.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights
    27.03.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos to Present at Upcoming Virtual Investor Conferences in March and April
    14.03.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos to Participate in the Leerink Partners Global Biopharma Conference 2024
    05.03.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos Presents Positive Preclinical Efficacy Data for SAT-3247 at the 2024 MDA Clinical & Scientific Conference
    04.03.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos Recognized as a Top 50 TSX Venture Exchange Company
    21.02.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos Announces Upcoming Presentations at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference
    20.02.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos to Commence Trading on the Toronto Stock Exchange
    14.02.24 · Business Wire (engl.) · Satellos Bioscience
    Satellos Announces Promising Preliminary Data in Facioscapulohumeral Muscular Dystrophy
    13.02.24 · Business Wire (engl.) · Satellos Bioscience